Stay updated with breaking news from Containing Same. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
When weighing whether to issue its injunctive-type remedies—exclusion and cease-and-desist orders—the United States International Trade Commission (“Commission”) is not required to...
On January 26, 2022, the ITC issued a Notice of Investigation in Certain Adalimumab, Processes for Manufacturing or Relating to Same, and Products Containing Same(Inv. No. 337-TA-1296).
Unlocking A Public Interest Exemption Based On A Questionnaire - Synopsis: Upon consideration of the public interest factors, the Commission recently allowed the use of...
On December 21, 2021, ALJ Clark S. Cheney issued the public version (Part I, Part II, Part III) of his November 19, 2021 final initial determination ("ID") finding no violation of section 337...
November brought another busy month for the ITC. Final Determinations were issued by the Commission in two Section 337 Investigations: Certain Electronic Devices, Including Streaming...